Skip to content

The Effects of Focal Vibration on Spasticity in Multiple Sclerosis Patients

The Effects of Focal Vibration on Central and Peripheral Spasticity in Multiple Sclerosis Patients. A Randomized, Multicenter, Double Blinded vs Placebo Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02848898
Enrollment
60
Registered
2016-07-29
Start date
2016-08-31
Completion date
2017-07-31
Last updated
2016-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Focal Vibrations, Neurorehabilitation, Spasticity, Multiple Sclerosis

Brief summary

This trial consists of application of little devices (named Equistasi®) generating focal vibrations to treat spasticity in neurological patients, affected by multiple sclerosis. The expected effects are on gait and postural instability.

Interventions

DEVICEEquistasi
OTHERPlacebo

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Multiple Sclerosis affected * Spasticity * EDSS (Expanded Disability Status Scale) 0 - 5,5 * Patients able to sign informed consent

Exclusion criteria

* Age less than 18 years old and more than 65 years old * Pacemaker * Pregnancy * Comorbidities as: cancer, hypertension not controlled by drugs * concurrent therapies with antidepressant or corticosteroids

Design outcomes

Primary

MeasureTime frameDescription
Double support timeone yeardouble support time measured in seconds
First step lengthone yearfirst step length in cm
Swing phaseone yearswing phase measured in seconds
Stance phaseone yearstance phase measured in seconds
Gait Velocityone yearevaluation of gait velocity in m/s

Secondary

MeasureTime frameDescription
H/M ratioone yearevaluation of neurophysiological modifications in treated patients vs placebo group, as ratio between H max and M max in tibial posterior nerve, in Unit
Berg Balance Scaleone yearEvaluation of balance with a self administered scale, measured in Unit
Modified Fatigue Scaleone yearevaluation of fatigue with a self administered scale, measured in Unit

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026